234 related articles for article (PubMed ID: 18176935)
1. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers.
Wei Y; Xia W; Zhang Z; Liu J; Wang H; Adsay NV; Albarracin C; Yu D; Abbruzzese JL; Mills GB; Bast RC; Hortobagyi GN; Hung MC
Mol Carcinog; 2008 Sep; 47(9):701-6. PubMed ID: 18176935
[TBL] [Abstract][Full Text] [Related]
2. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
[TBL] [Abstract][Full Text] [Related]
3. The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers.
Bae WK; Yoo KH; Lee JS; Kim Y; Chung IJ; Park MH; Yoon JH; Furth PA; Hennighausen L
Mol Carcinog; 2015 Oct; 54(10):1172-80. PubMed ID: 25043748
[TBL] [Abstract][Full Text] [Related]
4. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
Li Y; Guo D; Sun R; Chen P; Qian Q; Fan H
Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241
[TBL] [Abstract][Full Text] [Related]
5. H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes.
Day CA; Hinchcliffe EH; Robinson JP
Cells; 2022 Oct; 11(21):. PubMed ID: 36359771
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma.
He LR; Liu MZ; Li BK; Rao HL; Liao YJ; Guan XY; Zeng YX; Xie D
BMC Cancer; 2009 Dec; 9():461. PubMed ID: 20028503
[TBL] [Abstract][Full Text] [Related]
7. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.
Rogenhofer S; Kahl P; Mertens C; Hauser S; Hartmann W; Büttner R; Müller SC; von Ruecker A; Ellinger J
BJU Int; 2012 Feb; 109(3):459-65. PubMed ID: 21810159
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer.
He LJ; Cai MY; Xu GL; Li JJ; Weng ZJ; Xu DZ; Luo GY; Zhu SL; Xie D
Asian Pac J Cancer Prev; 2012; 13(7):3173-8. PubMed ID: 22994729
[TBL] [Abstract][Full Text] [Related]
9. H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma.
Cai MY; Tong ZT; Zhu W; Wen ZZ; Rao HL; Kong LL; Guan XY; Kung HF; Zeng YX; Xie D
Mol Med; 2011; 17(11-12):1137-45. PubMed ID: 21738951
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.
Tang G; Guo J; Zhu Y; Huang Z; Liu T; Cai J; Yu L; Wang Z
Int J Oncol; 2018 Jun; 52(6):1899-1911. PubMed ID: 29620187
[TBL] [Abstract][Full Text] [Related]
11. Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma.
Jakobsson ME; Moen A; Davidson B; Falnes PØ
PLoS One; 2015; 10(10):e0140168. PubMed ID: 26448330
[TBL] [Abstract][Full Text] [Related]
12. Induction of aberrant trimethylation of histone H3 lysine 27 by inflammation in mouse colonic epithelial cells.
Takeshima H; Ikegami D; Wakabayashi M; Niwa T; Kim YJ; Ushijima T
Carcinogenesis; 2012 Dec; 33(12):2384-90. PubMed ID: 22976929
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of H3K27me3 in human ovarian carcinomas correlates with more aggressive tumor behavior and poor patient survival.
He WP; Li Q; Zhou J; H ZS; Kung HF; Guan XY; Xie D; Yang GF
Neoplasma; 2015; 62(6):932-7. PubMed ID: 26458314
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent clinical prognostic value of histone modifications in colorectal cancer.
Goossens-Beumer IJ; Benard A; van Hoesel AQ; Zeestraten EC; Putter H; Böhringer S; Liefers GJ; Morreau H; van de Velde CJ; Kuppen PJ
Transl Res; 2015 May; 165(5):578-88. PubMed ID: 25488396
[TBL] [Abstract][Full Text] [Related]
15. Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study.
Healey MA; Hu R; Beck AH; Collins LC; Schnitt SJ; Tamimi RM; Hazra A
Breast Cancer Res Treat; 2014 Oct; 147(3):639-51. PubMed ID: 25224916
[TBL] [Abstract][Full Text] [Related]
16. Hypo-trimethylation of Histone H3 Lysine 4 and Hyper-tri/dimethylation of Histone H3 Lysine 27 as Epigenetic Markers of Poor Prognosis in Patients with Primary Central Nervous System Lymphoma.
Kim HG; Kim MS; Lee YS; Lee EH; Kim DC; Lee SH; Kim YZ
Cancer Res Treat; 2022 Jul; 54(3):690-708. PubMed ID: 34793663
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Histone H3 Lysine 27 Trimethylation Is Associated with Aggressiveness and Dedifferentiation of Thyroid Cancer.
Tsai CC; Chien MN; Chang YC; Lee JJ; Dai SH; Cheng SP
Endocr Pathol; 2019 Dec; 30(4):305-311. PubMed ID: 31396854
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
19. Synthetic trimethyllysine receptors that bind histone 3, trimethyllysine 27 (H3K27me3) and disrupt its interaction with the epigenetic reader protein CBX7.
Tabet S; Douglas SF; Daze KD; Garnett GA; Allen KJ; Abrioux EM; Quon TT; Wulff JE; Hof F
Bioorg Med Chem; 2013 Nov; 21(22):7004-10. PubMed ID: 24100156
[TBL] [Abstract][Full Text] [Related]
20. Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer.
Borkiewicz L
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]